Study shows drug reduces heart attack risk by 40%
Ivabradine, manufactured in Co Wicklow, has also cut the incidence of heart surgery and other surgical procedures by more than half in angina patients, according to a global study on heart disease.
The results of the research – known as the BEAUTIFUL study – were presented yesterday at the European Society of Cardiology (ESC) Congress in Barcelona.
Lunchtime News
Newsletter
Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.



